, Singapore

Daily Markets Briefing: STI up 0.61%

Expect muted gains today.

The Straits Times Index (STI) ended 20.03 points or 0.61% higher to 3280.87, taking the year-to-date performance to -3.59%.

The top active stocks were DBS, which gained 1.05%, OCBC Bank, which is up 0.69%, UOB, which rose 1.45%, Singtel, which gained 0.32% and Genting Sing, with a 1.67% advance.

The FTSE ST Mid Cap Index gained 0.67%, whilst the FTSE ST Small Cap Index slipped 0.04%.

OCBC Investment Research noted that US stocks closed off session highs, though still in positive territory, as equity benchmarks attempted to recover some of the sharp losses from the previous session.

Six out of eleven S&P 500 industries ended higher. The best performers were Energy (1.40%) and Consumer Discretionary (0.68%), and worst performers were Consumer Staples (-0.45%) and Telecommunication Services (-0.42%).

"Despite the modest rebound on Wall Street overnight, we expect the overall sentiment to remain cautious today as uncertainty over trade disputes remains in focus," OCBC Investment Research said.

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare